Ocular Therapeutix (OCUL) Times Interest Earned (2013 - 2026)
Ocular Therapeutix's (OCUL) quarterly Times Interest Earned came in at -$33.61 in Q1 2026, down 56.92% year-on-year from -$78.02 in Q1 2025, and down 143.32% quarter-over-quarter from -$13.81 in Q4 2025.
Ocular Therapeutix (OCUL) Times Interest Earned (2013 - 2026) Analysis & Trends
Ocular Therapeutix's Times Interest Earned history runs 14 years deep, the most recent figure standing at -$33.61 for Q1 2026.
- On a quarterly basis, Times Interest Earned fell 56.92% year-over-year to -$33.61 in Q1 2026; TTM through Mar 2026 was -$21.63, a 32.58% decrease from a year earlier, with the FY2025 full-year figure at -$0.92, down 21.07% from the prior year.
- Times Interest Earned declined to -$33.61 in Q1 2026 per OCUL's latest filing, from -$13.81 in the prior quarter.
- Across five years, Times Interest Earned topped out at $7.37 in Q4 2022 and bottomed at -$33.61 in Q1 2026.
- The 5-year median for Times Interest Earned is -$12.75 (2023), against an average of -$12.87.
- Across the five-year window, Times Interest Earned jumped 168.63% in 2022 and slumped 778.49% in 2025, its largest moves.
- Year by year, Times Interest Earned stood at $7.37 in 2022, then plunged by 132.1% to -$2.37 in 2023, then plunged by 588.12% to -$16.28 in 2024, then gained by 15.17% to -$13.81 in 2025, then sank by 143.32% to -$33.61 in 2026.
- Per Business Quant, the three latest OCUL Times Interest Earned figures stand at -$33.61 (Q1 2026), -$13.81 (Q4 2025), and -$22.88 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Ocular Therapeutix | 1.91 Bn | 1.91 Bn | 9.46 Mn | -33.61 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.61 |
| Dec 31, 2025 | -13.81 |
| Sep 30, 2025 | -22.88 |
| Jun 30, 2025 | -22.43 |
| Mar 31, 2025 | -21.42 |
| Dec 31, 2024 | -16.28 |
| Sep 30, 2024 | -14.27 |
| Jun 30, 2024 | -13.64 |
| Mar 31, 2024 | -2.44 |
| Dec 31, 2023 | -2.37 |
| Sep 30, 2023 | -5.61 |
| Jun 30, 2023 | -10.33 |
| Mar 31, 2023 | -12.75 |
| Dec 31, 2022 | 7.37 |
| Sep 30, 2022 | -11.99 |
| Jun 30, 2022 | -11.74 |
| Mar 31, 2022 | -10.60 |
| Dec 31, 2021 | -10.74 |
| Sep 30, 2021 | -11.78 |
| Jun 30, 2021 | -12.22 |